Cleopatra Hospitals Group results, Fiscal year 2024
Net profit, assets, equity and cash flow for Fiscal year 2024, against the same period a year earlier, from the published financial statements.
Net profit191 millionEGP · −54.3% vs the same period a year earlier
Total assets7.59 billionEGP · +69.1% vs the same period a year earlier
Shareholders' equity3.18 billionEGP · +29.9% vs the same period a year earlier
Operating cash flow1.5 billionEGP · +168.8% vs the same period a year earlier
In short
- Cleopatra Hospitals Group's net profit for Fiscal year 2024 was about 191 million EGP, down −54.3% from 418 million EGP in Fiscal year 2023.
- Total assets at the end of Fiscal year 2024 were about 7.59 billion EGP, and shareholders' equity about 3.18 billion EGP.
- Operating cash flow for Fiscal year 2024 was positive at 1.5 billion EGP.
Key lines against the same period a year earlier
This periodFiscal year 2023Change
Net profit191 million418 million−54.3%
Gross profit2.2 billion408 million+438.7%
Total assets7.59 billion4.49 billion+69.1%
Total liabilities4.41 billion2.04 billion+116.1%
Shareholders' equity3.18 billion2.45 billion+29.9%
Total liabilities and equity7.59 billion4.49 billion+69.1%
Operating cash flow1.5 billion558 million+168.8%
Investing cash flow-617 million-798 million+22.6%
Financing cash flow1.28 billion153 million+739.0%
Net change in cash77.62 million15.05 million+415.8%
Figures in EGP from the published statement summaries (consolidated where the company publishes consolidated statements), after normalising reporting units across periods. The exact figure is in the attached report, which may be the standalone version.
Cleopatra Hospitals Group's Q3 2026 results, the day they are published
One email on the day, no account, and a one-click stop in the email itself.
By subscribing you agree to receive these alerts only. Privacy policy